1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists

The cannabinoid receptor 2 (CB2 receptor) has attracted considerable interest, mainly due to its potential as a target for therapeutics for treating various diseases that have a neuroinflammatory or neurodegenerative component while avoiding the adverse psychotropic effects that accompany CB1 recept...

Full description

Saved in:
Bibliographic Details
Main Authors: Amer H. Tarawneh, Pankaj Pandey, Lo'ay A. Al-Momani, Anastassiya V. Gadetskaya, Sultan T. Abu-Orabi, Robert J. Doerksen, Stephen J. Cutler
Format: article
Language:EN
Published: Elsevier 2022
Subjects:
Online Access:https://doaj.org/article/e155f8c981fa43f99cbbbced5bbfc653
Tags: Add Tag
No Tags, Be the first to tag this record!